The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
High levels of cell-free DNA (cfDNA) at baseline (BL) and increase of at least one mutation at day 14 (D14) as independent prognostic biomarkers for patients (pts) with advanced colorectal cancer (aCRC) under regorafenib.
 
Pashalina Kehagias
No Relationships to Disclose
 
Caroline Vandeputte
No Relationships to Disclose
 
Lieveke Ameye
No Relationships to Disclose
 
Hakim El Housni
Consulting or Advisory Role - Novartis (Inst)
 
Amélie Deleporte
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer
 
Karen Paula Geboes
Consulting or Advisory Role - Ipsen
Travel, Accommodations, Expenses - Ipsen; Merck; Novartis; Roche
 
Thierry Delaunoit
No Relationships to Disclose
 
Marc Peeters
Honoraria - Bayer
Consulting or Advisory Role - Bayer
Speakers' Bureau - Bayer
Travel, Accommodations, Expenses - Bayer
 
Gauthier Demolin
No Relationships to Disclose
 
Lionel A. D'Hondt
No Relationships to Disclose
 
Jozef Janssens
No Relationships to Disclose
 
Javier Carrasco
Honoraria - Roche
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - Amgen
 
Stephane Holbrechts
No Relationships to Disclose
 
Jean-Charles Goeminne
No Relationships to Disclose
 
Philippe Vergauwe
No Relationships to Disclose
 
Jean-Luc Van Laethem
No Relationships to Disclose
 
Ghanem Ghanem
No Relationships to Disclose
 
Marianne Paesmans
No Relationships to Disclose
 
Patrick Flamen
Consulting or Advisory Role - Bayer (Inst); Sirtex Medical (Inst)
Speakers' Bureau - Bayer; Ipsen; Novartis; Sirtex Medical
Research Funding - Bayer (Inst); Roche (Inst)
 
Alain Hendlisz
Research Funding - Bayer (Inst)